I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Undervalued Stocks on AMEX
Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.
In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on AMEX
Today’s data is for companies listed on the American Stock Exchange.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| CQP | Cheniere Energy Partners LP | 2017 | 32.700000 | 37.0000 | USD | 3 |
| TXMD | TherapeuticsMD Inc | 2017 | 6.630000 | 24.5000 | USD | 2 |
| MAG | MAG Silver Corp | 2017 | 14.160000 | 24.6368 | CAD | 9 |
| PARR | Par Pacific Holdings Inc | 2017 | 15.440000 | 23.0000 | USD | 1 |
| SAND | Sandstorm Gold Ltd | 2017 | 4.030000 | 7.5357 | CAD | 7 |
| REI | Ring Energy Inc | 2017 | 12.210000 | 17.1667 | USD | 3 |
| STRP | Straight Path Communications Inc | 2017 | 32.890000 | 56.0000 | USD | 1 |
| BTX | BioTime Inc | 2017 | 3.450000 | 10.0000 | USD | 1 |
| BRG | Bluerock Residential Growth REIT Inc | 2017 | 12.580000 | 16.0000 | USD | 3 |
| ESTE | Earthstone Energy Inc | 2017 | 13.160000 | 18.0000 | USD | 3 |
| SENS | Senseonics Holdings Inc | 2017 | 2.240000 | 6.0000 | USD | 1 |
| MCF | Contango Oil & Gas Co | 2017 | 7.680000 | 11.5000 | USD | 2 |
| AST | Asterias Biotherapeutics Inc | 2017 | 3.650000 | 12.0000 | USD | 1 |
| PFNX | Pfenex Inc | 2017 | 7.340000 | 25.0000 | USD | 1 |
| SPP | Sanchez Production Partners LP | 2017 | 12.550000 | 17.0000 | USD | 1 |
| VISI | Volt Information Sciences Inc | 2017 | 7.050000 | 14.0000 | USD | 1 |
| DLA | Delta Apparel Inc | 2017 | 17.550000 | 26.0000 | USD | 1 |
| UUUU | Energy Fuels Inc | 2017 | 2.070000 | 6.4154 | CAD | 1 |
| USAPF | Americas Silver Corp | 2017 | 3.190000 | 6.7833 | CAD | 3 |
| BGSF | BG Staffing Inc | 2017 | 13.360000 | 17.5750 | USD | 2 |
| VNRX | VolitionRX Ltd | 2017 | 4.370000 | 10.0000 | USD | 2 |
| UFAB | Unique Fabricating Inc | 2017 | 11.400000 | 17.0000 | USD | 1 |
| SYN | Synthetic Biologics Inc | 2017 | 0.785400 | 7.0000 | USD | 1 |
| CRMD | Cormedix Inc | 2017 | 2.180000 | 6.5000 | USD | 1 |
| JOB | GEE Group Inc | 2017 | 4.730000 | 10.0000 | USD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
STRP:ASE Straight Path Comms
http://www.spathinc.com
Straight Path Comms has 9 employees and is headquartered in United States.
Straight Path Communications Inc provides services to internet service and telecommunications providers. It holds licenses for fixed wireless spectrum in the United States, providing broad geographic coverage.
BTX:ASE BioTime
http://www.biotimeinc.com
BioTime has 133 employees and is headquartered in United States.
BioTime Inc is a biotechnology company. The Company is engaged in the biomedical research and product development in regenerative medicine including human embryonic stem cell and induced pluripotent stem cell technology.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.